Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity Downgrades Bioventus to Hold

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

November 9, 2022

1 minute read

Canaccord Genuity analyst Kyle Rose downgrades Bioventus (NASDAQ:BVS) from Buy to Hold.

HC Wainwright & Co. Maintains Buy on Arcadia Biosciences, Lowers Price Target to $3

August 26, 6:25 AM

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Arcadia Biosciences (NASDAQ:RKDA) with a Buy and lowers the price target from $4 to $3.

July 6, 5:02 PM

Levi Strauss & Co (NYSE: LEVI) shares are trading lower in Thursday's after-hours session on the heels of the company's second-quarter report.

December 7, 8:32 AM

The Nasdaq 100 closed lower by around 90 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

December 7, 9:00 PM

Bitcoin and Ethereum traded lower on Wednesday evening as the global cryptocurrency market cap dropped 1.8% to $841.15 billion at 7:21 p.m. EST.